drugset / Trial / NCT03852849
Rapid Build of HIV Related Protective Barriers
Unknown
600 enrolled
National Center for AIDS/STD Control and Prevention, China CDC
Yunnan AIDS Care Center · collabYunnan Center for Disease Control and Prevention · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of the study is to screen the optimal intervention strategies to rapid establish the protective barriers against HIV-infection by maximally decreasing the viremia among HIV- infected patients.
Timeline
- Start
- 2019-03-01
- Primary completion
- 2020-12-31
- Completion
- 2021-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EFV | Unknown | 400 mg | — |
Indications
No indication recorded.